Change in the oestrogen receptor status of breast cancer with age - comparison of two types of assay
1992

Change in Oestrogen Receptor Status of Breast Cancer with Age

Sample size: 189 publication Evidence: moderate

Author Information

Author(s): D.J. Gaskell, K. Sangster, A.L. Tesdale, D. Carson, R.A. Hawkins

Primary Institution: University Department of Surgery, The Royal Infirmary, Edinburgh

Hypothesis

Does the oestrogen receptor status of breast cancer change with age?

Conclusion

The study concludes that older patients tend to have a higher proportion of oestrogen receptor-positive tumours, which may affect their response to endocrine therapy.

Supporting Evidence

  • There was a strong correlation between the two assays used to measure oestrogen receptor levels.
  • Older patients had a higher proportion of oestrogen receptor-positive tumours.
  • The intensity of staining for oestrogen receptors increased with age.

Takeaway

As people get older, their breast cancer is more likely to have oestrogen receptors, which can influence how well treatments work.

Methodology

The study used immunocytochemical assays and radioligand-binding assays to measure oestrogen receptor status in breast cancer patients.

Limitations

The study may not account for all factors influencing oestrogen receptor status and response to therapy.

Participant Demographics

Mean age of participants was 67 years, with a range from 35 to 86 years.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication